Attached files
| file | filename |
|---|---|
| EX-99.1 - INVESTOR PRESENTATION - Brooklyn ImmunoTherapeutics, Inc. | ntn_8k-ex9901.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
________________
Date of Report (Date of earliest event reported): March 11, 2014
NTN BUZZTIME, INC.
(Exact name of Registrant as Specified in Charter)
| Delaware | 001-11460 | 31-1103425 |
|
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
| 2231 Rutherford Rd. Suite 200 | |
| Carlsbad, California | 92008 |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (760) 438-7400
________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01 Other Events
As previously announced, on Tuesday March 11, 2014, our Interim Chief Executive Officer, Jeffrey Berg, presented at the 26th Annual Roth Conference. Attached as an exhibit to this report are the written presentation materials used at the conference, a copy of which is also available under the “Webcasts & Presentations” tab of our website located at www.buzztimebusiness.com/investor-relations/.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| 99.1 | Investor presentation dated March 11, 2014. |
| 2 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
| NTN BUZZTIME, INC. | ||
| By: | /s/ Kendra Berger | |
| Kendra Berger Chief Financial Officer | ||
Date: March 14, 2014
| 3 |
EXHIBIT INDEX
| Exhibit No. | Document |
| 99.1 | Investor presentation dated March 11, 2014. |
| 4 |